Click to view this email in a browser

newsletter header oct2.jpg

tido_presentation_dsc8244newsletter test.jpg

Children's Technology Development Fund Awards $1.2M to Hospital Researchers

The Children's Hospital Boston Technology Development Fund announced that it will invest $1.2M in 11 hospital innovations that span pharmaceuticals, diagnostics, medical devices, vaccines, and tissue engineering. [read more]

New Technology Listings

Therapeutics:

Novel Treatment for Polycystic Kidney Disease (PKD)               

        Keywords:
Therapeutics, Urology, Animal Model (mouse)

      Lead Investigator: Jordan Kreidberg, MD, PhD

Injectable Therapeutic for Heart Failure       

        Keywords:
Therapeutics, Cardiovascular/Cardiology, Regenerative Medicine, Large Molecule

      Lead Investigator: Bernhard Kuhn, MD

Novel Pneumococcal Vaccine with Adjuvant Properties     

        Keywords: Therapeutics, Immunology, Infectious Disease, Pediatric
      Lead Investigator: Richard Malley, MD

Diagnostics:

Test for Developmental Delay or Autism      

        Keywords: Diagnostic/Prognostic, Genetic Disease, Neonatology/Pediatric, Neurology, Biomarker
      Lead Investigator: Bai-Lin Wu, PhD, M Med, FACMG

Highly Sensitive Test for Acute Appendicitis        

        Keywords: Diagnostic/Prognostic, Gastrointestinal/Nutrition, Inflammation, Biomarker
      Lead Investigator: Alex Kentsis, MD, PhD

Chromosomal Instability Signature Predicts Prognosis in Cancer        

        Keywords: Diagnostic/Prognostic, Oncology/Hematology, Biomarker
      Lead Investigator: Zoltan Szallasi, MD

Devices:

Hydration Monitor        

        Keywords: Neonatology/Pediatric, Medical Device
      Lead Investigator: Vassilios Bezzerides, MD, PhD

*To search the full list of technologies, click [here]


New Issued Patents

Leonard I. Zon  |  US 7,521,055  |  Ferroportin1 Antibodies and Methods

Judah Folkman  |  US 7,524,811  |  Anti-Antigenic Peptides from the N-Terminus of Endostatin

Stephen Harrison  |  US 7,524,624  | Novel Inhibition of Dengue Infection 

Mark Puder  |  US 7,527,123  |  Patient-Friendly Stethoscope

Wayne Lencer  |  US 7,547,436 Receptor Specific Transepithelial Transport of Therapeutics

Zhigang He  |  US 7,524,640 |  Inhibiting Smad Signaling Promotes Neuron Regeneration

Atul Butte  |  US 7,576,052 |  Methods and Compositions for Modulating Adipocyte Function


New Scientific Publications

Bersell K, Arab S, Haring B, Kuhn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009 Jul 23;138(2):257-70. PMID: 19632177

Kang SY, Halvorsen OJ, Gravdal K, Bhattacharya N, Lee JM, Liu NW, Johnston BT, Johnston AB, Haukaas SA, Aamodt K, Yoo S, Akslen LA, Watnick RS. Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. Proc Natl Acad Sci U S A. 2009 Jul 6. PMID: 19581582

Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009 Jul 9;460(7252):259-63. Epub 2009 Jun 10. PMID: 19516257

Kentsis A, Lin YY, Kurek K, Calicchio M, Wang YY, Monigatti F, Campagne F, Lee R, Horwitz B, Steen H, Bachur R. Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Ann Emerg Med. 2009 Jun 25. PMID: 19556024

North TE, Goessling W, Peeters M, Li P, Ceol C, Lord AM, Weber GJ, Harris J, Cutting CC, Huang P, Dzierzak E, Zon LI. Hematopoietic stem cell development is dependent on blood flow. Cell. 2009 May 15;137(4):736-48. PMID: 19450519

Epstein-Barash H, Shichor I, Kwon AH, Hall S, Lawlor MW, Langer R, Kohane DS. Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7125-30. Epub 2009 Apr 13. PMID: 19365067


CHB Research in the News

Biotech Transfer Week: Children's Hospital Boston Debuts Biomedical Technology Development Fund

TIME: Is a Swine Flu Outbreak Coming? Ask Your iPhone

Reuters: Drug-Dispensing Contact Lens Passes Early Tests

Technology Review: Protein Treatment Repairs Heart Damage

New Scientist: First Heartbeats Trigger Blood Formation


The mission of the Technology and Innovation Development Office (TIDO) is to translate the laboratory and clinical research excellence of Children's Hospital Boston into products for the public benefit. TIDO uses a multi-faceted approach to promote, support and develop research, technology and clinical innovations through the protection and licensing of intellectual property, investing in Children's Hospital technologies, and establishing strong research and development partnerships with industry throughout the innovation to product life cycle.

Forward this message to a friend 

 



If you no longer wish to receive these emails, please click on the following link: Unsubscribe

Children's Hospital Boston
300 Longwood Ave.
Boston, MA 02115

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!